title: [Glivek in the therapy of some forms of Ph- and bcr/abl-negative myeloproliferative diseases and a myeloproliferative variant of idiopathic hypereosinophilic syndrome].
authors.forename: I S
authors.initials: IS
authors.lastname: Nemchenko
authors.forename: N D
authors.initials: ND
authors.lastname: Khoroshko
authors.forename: A G
authors.initials: AG
authors.lastname: Turkina
authors.forename: O Iu
authors.initials: OIu
authors.lastname: Vinogradova
authors.forename: M A
authors.initials: MA
authors.lastname: Sokolova
authors.forename: E M
authors.initials: EM
authors.lastname: Abakumov
authors.forename: E A
authors.initials: EA
authors.lastname: Semenova
authors.forename: A V
authors.initials: AV
authors.lastname: Zakharova
authors.forename: E V
authors.initials: EV
authors.lastname: Domracheva
mesh_terms: D000328:Adult; D001549:Benzamides; D004804:Eosinophils / Q000187:drug effects; D016044:Fusion Proteins, bcr-abl / Q000032:analysis*; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D000068877:Imatinib Mesylate; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D016133:Polymerase Chain Reaction; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl
vernacular_title: Glivek v terapii nekotorykh form Ph'- i bcr/abl-negativnykh mieloproliferativnykh zabolevaniĭ i mieloproliferativnogo varianta idiopaticheskogo giperéozinofil'nogo sindroma.